Book a Demo
Oliver Barnes
Gray shield icon
Is this you?
Claim your profile.

Oliver Barnes

Us Pharmaceutical And Biotech Correspondent

AS SEEN ON
Financial Times, The Australian Financial Review

Preston's Summary

Oliver Barnes is a US pharmaceutical and biotech correspondent at the Financial Times. He focuses on scientific innovation, blockbuster drugs, and access to healthcare, drawing on his extensive experience covering various sectors including gambling and hospitality. Oliver has been featured in outlets such as The Irish Times, Yahoo Finance, and the Financial Post, and is recognized for his impactful journalism in the fields of finance and healthcare.

Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston

Geo Focus

United States (National)

Coverage Attributes:

Beta
Informative: 32 %
Promotional: 25 %
Private Sector Announcements: 8 %
Opinion: 7 %
Press Release: 5 %

Themes Covered:

Not enough data icon

Not enough data

Most Recent Topics:

  • Corporate Fraud
  • Financial Crimes
  • Insider Trading
  • Commercial Real Estate
  • Real Estate Investment
  • Beauty Industry
  • Journalism
  • Media
  • Press

Pitching Insights

Oliver Barnes covers a variety of topics related to the business sector, including investments, gambling, restaurants, and media. He also shows interest in sports and entertainment news. His articles often include private sector announcements as well as government announcements and press releases.

To effectively reach out to Oliver with pitches or insights, consider offering exclusive information about industry trends or market movements within the UK or providing expert commentary on developments affecting businesses in these sectors. If you have access to insider knowledge about companies' financial performances or strategic moves in the UK's business landscape, your pitch is likely to resonate with him.

When reaching out regarding sporting events or entertainment news related to businesses (e.g., sponsorships), ensure that your content aligns with his coverage focus on the national level within the United Kingdom.

This information evolves through artificial intelligence and human feedback. Improve this profile .

Journalists With Similar Coverage:

Based on similarity of content.
Antoine Gara

Antoine Gara

Editor
**********ra@*****m
Publications
Financial Times, The Australian Financial Review
Most recent topics
Not enough data
Arash Massoudi

Arash Massoudi

Finance And Markets Editor
***********udi@*****m
Publications
Financial Times, The Australian Financial Review
Most recent topics
Not enough data
Kelsey Vlamis

Kelsey Vlamis

Senior Reporter
******s@***************.com
Publications
Business Insider, AOL, Inc., yahoo.com
Most recent topics
Not enough data
Ryan McMorrow

Ryan McMorrow

Corporate Tech Reporter
**********row@*****m
Publications
Financial Times
Most recent topics
Not enough data
Sujeet Indap

Sujeet Indap

Wall Street Editor
**********ap@*****m
Publications
Financial Times, The Australian Financial Review
Most recent topics
Not enough data
Patrick Temple-West

Patrick Temple-West

Governance Reporter
**************west@*****m
Publications
Financial Times, The Australian Financial Review
Most recent topics
Not enough data

Articles

Financial Times

How AI has changed M&A

How AI has changed M&A

By: James Fontanella-Khan, Oliver Barnes, Sujeet Indap, Arash Massoudi, Ryan Mcmorrow

The size of deals is hitting new peaks, unloved companies are becoming sexy and PE has found a new gold mine

© 2026 Intelligent Relations